These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4442550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C, Jonsson G.
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.
    Hedreen JC, Chalmers JP.
    Brain Res; 1972 Nov 27; 47(1):1-36. PubMed ID: 4345031
    [No Abstract] [Full Text] [Related]

  • 7. Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.
    Sotelo C, Javoy F, Agid Y, Glowinski J.
    Brain Res; 1973 Aug 30; 58(2):269-90. PubMed ID: 4756130
    [No Abstract] [Full Text] [Related]

  • 8. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.
    Ichitani Y, Okamura H, Matsumoto Y, Nagatsu I, Ibata Y.
    Brain Res; 1991 May 24; 549(2):350-3. PubMed ID: 1679369
    [Abstract] [Full Text] [Related]

  • 9. Degeneration of noradrenergic nerve terminals in submucous ganglia of the rat duodenum following treatment with 6-hydroxydopamine.
    Wong WC, Helme RD, Smith GC.
    Experientia; 1974 Mar 15; 30(3):282-4. PubMed ID: 4824608
    [No Abstract] [Full Text] [Related]

  • 10. Effect of 6-hydroxydopamine on the level of the catecholamines in the brain of developing rats.
    Brus R.
    Arch Int Pharmacodyn Ther; 1973 Jan 15; 201(1):71-6. PubMed ID: 4717390
    [No Abstract] [Full Text] [Related]

  • 11. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C.
    J Neurochem; 1973 Jun 15; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract] [Full Text] [Related]

  • 12. The effects of spinal cord transection and intracisternal 6-hydroxydopamine on phenylethanolamine-N-methyl transferase (PNMT) activity in rat brain stem and spinal cord.
    Reid JL, Zivin JA, Kopin IJ.
    J Neurochem; 1976 Mar 15; 26(3):629-31. PubMed ID: 1063254
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex.
    Kalisker A, Rutledge CO, Perkins JP.
    Mol Pharmacol; 1973 Sep 15; 9(5):619-29. PubMed ID: 4363016
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Facilitated aggression in the rat following 6-hydroxydopamine administration.
    Eichelman BS, Thoa NB, Ng KY.
    Physiol Behav; 1972 Jan 15; 8(1):1-3. PubMed ID: 4677199
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G, Lohmander S, Sachs C.
    Biochem Pharmacol; 1974 Sep 15; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract] [Full Text] [Related]

  • 19. Intracisternal neurotoxins and monoamine neurons innervating the spinal cord: acute and chronic effects on cell and axon counts and nerve terminal densities.
    Nygren LG, Olson L.
    Histochemistry; 1977 Jun 24; 52(4):281-306. PubMed ID: 885740
    [No Abstract] [Full Text] [Related]

  • 20. Evidence that punctate intracerebral administration of 6-hydroxydopamine fails to produce selective neuronal degeneration. Comparison with copper sulfate and factors governing the deportment of fluids injected into brain.
    Butcher LL, Eastgate SM, Hodge GK.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jun 24; 285(1):31-70. PubMed ID: 4155050
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.